174 related articles for article (PubMed ID: 26613097)
1. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria.
Chang CA; Meloni ST; Eisen G; Chaplin B; Akande P; Okonkwo P; Rawizza HE; Tchetgen Tchetgen E; Kanki PJ
Open Forum Infect Dis; 2015 Dec; 2(4):ofv154. PubMed ID: 26613097
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
Van Rie A; Westreich D; Sanne I
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
Pathmanathan I; Dokubo EK; Shiraishi RW; Agolory SG; Auld AF; Onotu D; Odafe S; Dalhatu I; Abiri O; Debem HC; Bashorun A; Ellerbrock T
PLoS One; 2017; 12(3):e0173309. PubMed ID: 28282390
[TBL] [Abstract][Full Text] [Related]
4. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
6. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
7. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
Assefa A; Gelaw B; Getnet G; Yitayew G
BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
[TBL] [Abstract][Full Text] [Related]
8. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
[TBL] [Abstract][Full Text] [Related]
9. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model.
Gatechompol S; Sophonphan J; Ubolyam S; Avihingsanon A; van Leth F; Cobelens F; Kerr SJ
BMC Infect Dis; 2022 Apr; 22(1):346. PubMed ID: 35387594
[TBL] [Abstract][Full Text] [Related]
10. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy.
Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A;
J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study.
Aemro A; Jember A; Anlay DZ
BMC Infect Dis; 2020 Mar; 20(1):245. PubMed ID: 32216747
[TBL] [Abstract][Full Text] [Related]
12. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019.
Melgar M; Nichols C; Cavanaugh JS; Kirking HL; Surie D; Date A; Ahmedov S; Maloney S; Fukunaga R; ;
MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(12):329-334. PubMed ID: 32214084
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
Anígilájé EA; Aderibigbe SA; Adeoti AO; Nweke NO
PLoS One; 2016; 11(5):e0156177. PubMed ID: 27232185
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.
Akanbi MO; Achenbach CJ; Feinglass J; Taiwo B; Onu A; Pho MT; Agbaji O; Kanki P; Murphy RL
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):931-7. PubMed ID: 23316724
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study.
Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
BMC Med; 2015 Apr; 13():70. PubMed ID: 25889688
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
19. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
